These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37652682)

  • 21. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
    J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Covid-19 variants: Impact on transmissibility and virulence.
    Malik YA
    Malays J Pathol; 2022 Dec; 44(3):387-396. PubMed ID: 36591708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective Observational Study of Complete Blood Count (CBC) Parameters and ICU Mortality of COVID-19 Disease in Delta Variant and Omicron Variant in a Community-Based Hospital in New York City.
    Yadav R; Yadav V; Pokhriyal S; Zahid U; Gandhi A
    Cureus; 2023 Feb; 15(2):e34894. PubMed ID: 36925973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of Serial Interval and Reproduction Number to Quantify the Transmissibility of SARS-CoV-2 Omicron Variant in South Korea.
    Kim D; Ali ST; Kim S; Jo J; Lim JS; Lee S; Ryu S
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omicron variant in COVID-19 current pandemic: a reason for apprehension.
    Kamble P; Daulatabad V; Patil R; John NA; John J
    Horm Mol Biol Clin Investig; 2023 Mar; 44(1):89-96. PubMed ID: 36064193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
    Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
    Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus-2 Omicron Variant of Concern.
    Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2022 May; 94(5):2160-2166. PubMed ID: 35050521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19.
    Mohseni Afshar Z; Tavakoli Pirzaman A; Karim B; Rahimipour Anaraki S; Hosseinzadeh R; Sanjari Pireivatlou E; Babazadeh A; Hosseinzadeh D; Miri SR; Sio TT; Sullman MJM; Barary M; Ebrahimpour S
    Diagnostics (Basel); 2023 Feb; 13(3):. PubMed ID: 36766664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Omicron variant: Characteristics and prevention.
    He X; Hong W; Pan X; Lu G; Wei X
    MedComm (2020); 2021 Dec; 2(4):838-845. PubMed ID: 34957469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
    Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
    J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 Omicron variant: A next phase of the COVID-19 pandemic and a call to arms for system sciences and precision medicine.
    Mostafavi E; Dubey AK; Teodori L; Ramakrishna S; Kaushik A
    MedComm (2020); 2022 Mar; 3(1):e119. PubMed ID: 35281784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters.
    Yuan S; Ye ZW; Liang R; Tang K; Zhang AJ; Lu G; Ong CP; Man Poon VK; Chan CC; Mok BW; Qin Z; Xie Y; Chu AW; Chan WM; Ip JD; Sun H; Tsang JO; Yuen TT; Chik KK; Chan CC; Cai JP; Luo C; Lu L; Yip CC; Chu H; To KK; Chen H; Jin DY; Yuen KY; Chan JF
    Science; 2022 Jul; 377(6604):428-433. PubMed ID: 35737809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralizing antibody responses in vaccinated and unvaccinated individuals infected with Omicron BA.1 variant.
    Oh SJ; O SW; Choi YJ; Kim JM; Kim D; Kim IH; Park AK; Kim HM; Rhee JE; Jang YR; Yoo CK; Kim JY; Kim EJ
    J Clin Virol; 2022 Oct; 155():105253. PubMed ID: 35988369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Introduction and Rise of the Omicron Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant in Highly Vaccinated University Populations.
    Petros BA; Turcinovic J; Welch NL; White LF; Kolaczyk ED; Bauer MR; Cleary M; Dobbins ST; Doucette-Stamm L; Gore M; Nair P; Nguyen TG; Rose S; Taylor BP; Tsang D; Wendlandt E; Hope M; Platt JT; Jacobson KR; Bouton T; Yune S; Auclair JR; Landaverde L; Klapperich CM; Hamer DH; Hanage WP; MacInnis BL; Sabeti PC; Connor JH; Springer M
    Clin Infect Dis; 2023 Feb; 76(3):e400-e408. PubMed ID: 35616119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development.
    Islam MA; Shahi S; Marzan AA; Amin MR; Hasan MN; Hoque MN; Ghosh A; Barua A; Khan A; Dhama K; Chakraborty C; Bhattacharya P; Wei DQ
    Front Pharmacol; 2023; 14():1090717. PubMed ID: 36825152
    [No Abstract]   [Full Text] [Related]  

  • 36. Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks.
    Akaishi T; Ishii T
    J Int Med Res; 2022 May; 50(5):3000605221102079. PubMed ID: 35619217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nosocomial SARS-CoV-2 transmission in multi-bedded hospital cubicles over successive pandemic waves: Lower mortality but wider spread with Omicron despite enhanced infection-prevention measures.
    Wee LE; Conceicao EP; Aung MK; Aung MO; Yang Y; Arora S; Ko KK; Venkatachalam I
    Infect Dis Health; 2023 May; 28(2):81-87. PubMed ID: 37032572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular determinants associated with temporal succession of SARS-CoV-2 variants in Uttar Pradesh, India.
    Pal S; Mehta P; Pandey A; Ara A; Ghoshal U; Ghoshal UC; Pandey R; Tripathi RK; Yadav PN; Ravishankar R; Kundu TK; Rajender S
    Front Microbiol; 2023; 14():986729. PubMed ID: 36819024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and application of an RT‒PCR assay for the identification of the delta and omicron variants of SARS-COV-2.
    Shipulin GA; Savochkina Y; Shuryaeva AK; Glushchenko EE; Luparev AR; Polyakova VA; Danilov DI; Davydova EE; Vinogradov KS; Stetsenko IF; Aiginin AA; Matsvay AD; Kolbutova KB; Bogdan SA; Vashukova MA; Yudin SM
    Heliyon; 2023 Jun; 9(6):e16917. PubMed ID: 37287602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evolution of the spike protein and hACE2 interface of SARS-CoV-2 omicron variants determined by hydrogen bond formation.
    Yang YY; Tseng YJ
    Brief Funct Genomics; 2023 May; 22(3):291-301. PubMed ID: 36723978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.